Concentrix Corp (CNXC) stock
CNXCNasdaqServices-Business Services, NECFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 9/3069% below fair value
$30.27−0.36 (-1.18%)
Close on Nov 18, 2026Market cap $1.85BP/E –Yield –
Concentrix operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Concentrix's operating income for the twelve months ending Aug 31, 2026 was -$2.08B, down 441.5% year over year. For fiscal 2025 it was -$918.18M, down 254.0% from the year before. The highest annual figure on record is $661.33M in fiscal 2023.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | -$918.18M | -254.0% |
| FY2024 | Nov 30, 2024 | $596.39M | -9.8% |
| FY2023 | Nov 30, 2023 | $661.33M | +3.3% |
| FY2022 | Nov 30, 2022 | $640.19M | +11.8% |
| FY2021 | Nov 30, 2021 | $572.40M | +85.4% |
| FY2020 | Nov 30, 2020 | $308.76M | +4.9% |
| FY2019 | Nov 30, 2019 | $294.33M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Aug 31, 2026 | -$910.31M | -719.3% |
| Q2 FY2026CQ2 2026 | May 31, 2026 | $95.42M | -35.7% |
| Q1 FY2026CQ1 2026 | Feb 28, 2026 | $118.56M | -29.8% |
| Q4 FY2025CQ4 2025 | Nov 30, 2025 | -$1.38B | -1056.4% |
| Q3 FY2025CQ3 2025 | Aug 31, 2025 | $146.98M | -4.1% |
| Q2 FY2025CQ2 2025 | May 31, 2025 | $148.35M | -1.2% |
| Q1 FY2025CQ1 2025 | Feb 28, 2025 | $168.87M | +13.8% |
| Q4 FY2024CQ4 2024 | Nov 30, 2024 | $144.54M | -19.9% |
| Q3 FY2024CQ3 2024 | Aug 31, 2024 | $153.24M | -5.6% |
| Q2 FY2024CQ2 2024 | May 31, 2024 | $150.17M | -7.6% |
| Q1 FY2024CQ1 2024 | Feb 29, 2024 | $148.44M | -4.9% |
| Q4 FY2023CQ4 2023 | Nov 30, 2023 | $180.45M | +1.4% |
| Q3 FY2023CQ3 2023 | Aug 31, 2023 | $162.27M | +3.0% |
| Q2 FY2023CQ2 2023 | May 31, 2023 | $162.57M | +3.6% |
| Q1 FY2023CQ1 2023 | Feb 28, 2023 | $156.05M | +5.6% |
| Q4 FY2022CQ4 2022 | Nov 30, 2022 | $177.99M | +12.7% |
| Q3 FY2022CQ3 2022 | Aug 31, 2022 | $157.55M | +4.1% |
| Q2 FY2022CQ2 2022 | May 31, 2022 | $156.91M | +22.4% |
| Q1 FY2022CQ1 2022 | Feb 28, 2022 | $147.75M | +9.5% |
| Q4 FY2021CQ4 2021 | Nov 30, 2021 | $157.91M | +31.4% |
| Q3 FY2021CQ3 2021 | Aug 31, 2021 | $151.38M | +97.2% |
| Q2 FY2021CQ2 2021 | May 31, 2021 | $128.22M | +443.8% |
| Q1 FY2021CQ1 2021 | Feb 28, 2021 | $134.89M | +52.9% |
| Q4 FY2020CQ4 2020 | Nov 30, 2020 | $120.21M | – |
| Q3 FY2020CQ3 2020 | Aug 31, 2020 | $76.76M | – |
| Q2 FY2020CQ2 2020 | May 31, 2020 | $23.58M | – |
| Q1 FY2020CQ1 2020 | Feb 29, 2020 | $88.21M | – |
See a number that looks wrong?